ArticleScientific reports2025
Leveraging an ensemble of EfficientNetV1 and EfficientNetV2 models for classification and interpretation of breast cancer histopathology images.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Development and Preliminary Evaluation of an EfficientNet-Based Deep Learning System for Ultrasound Assessment of Neck Disorders: A Single-Center Study.Diagnostics (Basel, Switzerland) · 2026Article
- Leveraging medical imaging and deep learning for diagnosis of breast cancer using histopathological images.Scientific reports · 2026Article
- A Lightweight Cross-Gated Dual-Branch Attention Network for Colon and Lung Cancer Diagnosis from Histopathological Images.Medical sciences (Basel, Switzerland) · 2025Article
- Optimizing YOLOv11 for automated classification of breast cancer in medical images.Scientific reports · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Breast cancer is the second leading cause of cancer-related deaths among women, following lung cancer, as of 2024. Conventional cancer diagnosis relies on the manual examination of biopsied tissues by pathologists, a time-consuming process that may vary based on individual expertise. Early detection and accurate diagnosis are crucial for effective treatment planning and patient care. The advent of whole-slide scanners has revolutionized this process by enabling the use of Computer-Aided Detection (CAD) systems for automated analysis. In this study, we utilize state-of-the-art Convolutional Neural Networks (CNNs), specifically EfficientNetV1 and EfficientNetV2, for the binary classification of the BreakHis dataset-a collection of histopathological images categorized as benign or malignant breast tissues. To address the challenge of limited annotated data, we apply data augmentation and transfer learning techniques. Model interpretability is enhanced using the Grad-CAM technique, which generates localization maps highlighting critical regions relevant to predictions. Furthermore, ensemble learning is employed to improve classification performance. We utilize unweighted averaging and majority voting to combine predictions from multiple trained models. Additionally, we propose two ensemble architectures that integrate different trained EfficientNet models. Our framework achieves a classification accuracy of 99.58%, outperforming conventional CNN models on the BreakHis dataset. This study highlights the potential of ensemble learning to enhance diagnostic accuracy in breast cancer detection.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.